Va Northeast Ohio Healthcare System

Cleveland, Ohio 44106-1702

2 studies enrolling now · 8 studies all time

What they study most

Barrett Esophagus, Blood Pressure Management, COVID-19, Cirrhosis, Family History of Esophageal Cancer, HTN-Hypertension, Heart Failure, Hepatitis B, Hepatocellular Cancer, Hepatocellular Carcinoma, Liver Cancer, Marginal Zone Lymphoma

Studies at this site

• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart — Recruiting now
• Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux — Recruiting now
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
• Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals — Completed
• To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. — Completed
• ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk — Running, not enrolling
• Direct Carotid Sinus Nerve Stimulation in Anesthetized Human Subjects — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed